P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma

• Heidi Mocikova,
• Jana Markova,
• Lubica Gaherova,
• Maria Maco,
• Alice Sýkorová,
• David Belada,
• Marie Lukášová,
• Vit Prochazka,
• Juraj Duras,
• Tomas Kozak

Affiliations

Heidi Mocikova

1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic

Jana Markova

1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic

Lubica Gaherova

1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic

Maria Maco

1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic

Alice Sýkorová

2 University Hospital and Faculty of Medicine, 4th Department of Internal Medicine– Hematology, Hradec Kralove, Czech Republic

David Belada

2 University Hospital and Faculty of Medicine, 4th Department of Internal Medicine– Hematology, Hradec Kralove, Czech Republic

Marie Lukášová

3 Faculty of Medicine and Dentistry, Palacky University, Department of Haemato-Oncology, Olomouc, Czech Republic

Vit Prochazka

3 Faculty of Medicine and Dentistry, Palacky University, Department of Haemato-Oncology, Olomouc, Czech Republic

Juraj Duras

4 University Hospital and Faculty of Medicine, Department of Hemato-Oncology, Ostrava, Czech Republic

Tomas Kozak

1 University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Department of Hematology, Prague, Czech Republic